Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

36
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
36
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

31
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
31
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

42
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
42
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

73
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
73
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

36
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
36
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

54
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
54

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to DellaPergola and Zlochin.

The Lancet. Global health·2026
Same author

Aid withdrawal: an event study of mortality, vaccine coverage and DALY following transitioning from Gavi support.

BMJ global health·2026
Same author

ENPP1 buffers extracellular cGAMP in brown adipose tissue to limit insulin resistance.

bioRxiv : the preprint server for biology·2026
Same author

Violent and non-violent death tolls for the Gaza conflict: new primary evidence from a population-representative field survey.

The Lancet. Global health·2026
Same author

Development and External Validation of a Nomogram for Predicting Upper Gastrointestinal Bleeding in Patients After Percutaneous Coronary Intervention: A Retrospective Multicenter Cohort Study.

International journal of general medicine·2026
Same author

Piloting a Novel eHealth Technology for the Control and Management of Elevated Blood Pressure in Rwanda (HeartCare@Home Project): Protocol for a 2-Phase Crossover Study.

JMIR research protocols·2025

Related Experiment Video

Updated: Sep 20, 2025

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.8K

Cost-Effectiveness Analysis of Surgical Strategies Versus Medical Management for Rheumatic Heart Disease in Rwanda.

Vongai Mlambo1, Songnan Wang1, Maurice Musoni2

  • 1School of Medicine Stanford University Stanford CA.

Journal of the American Heart Association
|May 26, 2025
PubMed
Summary

Mechanical valve replacement is the most cost-effective surgical option for severe rheumatic heart disease in sub-Saharan Africa. This approach challenges the notion that such surgeries are uneconomical, offering improved life expectancy and health outcomes.

Keywords:
cardiac surgerycost‐effectivenessrheumatic heart diseasesub‐Saharan Africa

More Related Videos

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.8K
Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

812

Related Experiment Videos

Last Updated: Sep 20, 2025

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.8K
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.8K
Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

812

Area of Science:

  • Cardiovascular Surgery
  • Health Economics
  • Public Health

Background:

  • Rheumatic heart disease (RHD) disproportionately affects sub-Saharan Africa, with high mortality rates without surgical intervention.
  • Existing assumptions about the uneconomical nature of RHD surgery lack robust cost-effectiveness analysis.

Purpose of the Study:

  • To evaluate the cost-effectiveness of mechanical valve replacement, bioprosthetic valve replacement, and valve repair versus medical management for severe RHD in Rwanda.
  • To provide evidence-based data to inform surgical treatment decisions for RHD in resource-limited settings.

Main Methods:

  • A Markov model simulated disease progression for severe RHD patients.
  • Cost-effectiveness was assessed using microcosting and disability-adjusted life-years (DALYs), with a willingness-to-pay threshold of $2307 per DALY.
  • A 3% discount rate was applied to costs and DALYs.

Main Results:

  • Surgical interventions significantly extended life expectancy (7-13 years).
  • Mechanical and bioprosthetic valve replacements were cost-effective compared to medical management.
  • Mechanical valve replacement demonstrated the highest efficiency, averting 5.64 DALYs at an incremental cost-effectiveness ratio (ICER) of $1704 per DALY.

Conclusions:

  • Mechanical valve replacement is the most efficient surgical strategy for severe RHD in sub-Saharan Africa, refuting the perception of surgery being uneconomical.
  • Further cost-effectiveness improvements can be achieved by reducing surgical costs and optimizing anticoagulation management.